Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:03 PM
Ignite Modification Date:
2025-12-24 @ 7:03 PM
NCT ID:
NCT07303257
Eligibility Criteria:
Inclusion Criteria:
* Patient aged ≥ 18 years with indication for surgical treatment
* Interventions: Preserflo, Trabeculectomy and non-penetrating deep sclerectomy
* Beginning, moderate and severe uni or bilateral open or closed angle glaucoma
* Pseudoxexfoliative or pigmentary glaucoma
* Patient with consent to participate in research
Exclusion Criteria:
* Secondary causes of glaucoma: uveitic glaucoma, cortisone-induced glaucoma, traumatic glaucoma
* Congenital glaucoma
* Multi-operated refractory glaucoma
* Ophthalmological surgery within 6 months of inclusion
* Severe visual co-morbidities (age-related macular degeneration, severe diabetic retinopathy, retinal degeneration, etc.)
* Difficulty in organising follow-up (foreseeable poor cooperation from the patient, planned travel or absence during follow-up)
* Patient illiterate, unable to speak French or with impaired cognitive ability
* Patients with a significant pre-existing impairment in quality of life attributable to a progressive physical pathology or neuropsychiatric disorder.
* Patients under curatorship or guardianship
* Pregnant women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07303257
Study Brief:
Protocol Section:
NCT07303257